DIO3
DIO3 (iodothyronine deiodinase 3, also known as thyroxine 5-deiodinase or TXDI3) is a selenoenzyme that inactivates thyroid hormone by inner-ring deiodination. It limits exposure of developing tissues to active thyroid hormone and plays a critical role in mammalian development. Browse Assay Genie's current range of DIO3 research reagents below, or read on for the biology behind the target.
DIO3 plays a crucial role in the metabolism of thyroid hormones (TH), with specific roles in TH activation and inactivation by deiodination. It catalyses inner-ring deiodination of L-thyroxine (T4) to 3,3',5'-triiodothyronine (rT3) and of 3,5,3'-triiodothyronine (T3) to 3,3'-diiodothyronine (3,3'-T2). Both conversions yield inactive metabolites, so the enzyme removes the prohormone T4 and the bioactive hormone T3 from the active pool. It also acts on 3,5-T2, rT3 and 3,3'-T2 by inner-ring deiodination, and converts 3-monoiodothyronine to L-thyronine by outer-ring deiodination. In addition, it catalyses tyrosyl ring deiodination of several iodothyronamines.
The DIO3 gene is intronless and encodes a protein of the iodothyronine deiodinase family, which HGNC groups with the selenoproteins. DIO3 contains the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by a UGA codon, which normally signals termination; recognition of UGA as a Sec codon depends on a Sec insertion sequence (SECIS) stem-loop in the 3' UTR of the mRNA. UniProt places the protein at the cell membrane and endosome membrane. The enzyme is highly expressed in pregnant uterus, placenta, and foetal and neonatal tissues.
This expression pattern fits its proposed role in preventing premature exposure of developing foetal tissues to adult levels of thyroid hormones. By regulating circulating foetal thyroid hormone concentrations, DIO3 is critical for mammalian development. Knockout mice lacking the gene show abnormalities of development and reproduction. In infants with hemangiomas, increased activity of this enzyme causes severe hypothyroidism. The gene has also been called deiodinase, iodothyronine, type III. DIO1 and DIO2 are the other iodothyronine deiodinases.
DIO3 inactivates T4 and T3 by inner-ring deiodination, making it a key enzyme for studying how thyroid hormone signalling is attenuated.
High expression in placenta, pregnant uterus and foetal tissues, and developmental defects in knockout mice, make DIO3 relevant to foetal thyroid hormone control.
DIO3 carries selenocysteine at its active site, encoded by UGA and dependent on a SECIS element, making it a model for selenoprotein synthesis.
Increased DIO3 activity in infants with hemangiomas causes severe hypothyroidism, linking the enzyme to a defined thyroid-related disease mechanism.
DIO3 inactivates thyroid hormone. It deiodinates the inner ring of thyroxine (T4) to give reverse T3, and of T3 to give 3,3'-T2, both inactive. It is thought to protect developing foetal tissues from premature exposure to adult thyroid hormone levels.
DIO3 is the symbol for iodothyronine deiodinase 3. UniProt names the protein thyroxine 5-deiodinase, and TXDI3 is a listed alias. An earlier HGNC name was deiodinase, iodothyronine, type III. The enzyme is classified as EC 1.21.99.3.
Mouse and rat both have a Dio3 ortholog, and knockout mice show developmental and reproductive abnormalities. In infants with hemangiomas, raised enzyme activity causes severe hypothyroidism. Check the datasheet of any product for its validated reactivity.
Other iodothyronine deiodinases involved in thyroid hormone activation and inactivation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P55073; product specifications from Assay Genie datasheets.